Third Rock Ventures

Third Rock Ventures is a venture capital firm based in Boston, founded in 2007[2][nt 1] which invests in biotechnology startups.[3][4][5][6][7]

Third Rock Ventures
IndustryVenture capital
Founded2007
HeadquartersBoston, Massachusetts, United States
Key people
Mark J. Levin
Kevin P. Starr
Robert I. Tepper[1]
Websitethirdrockventures.com

Approach

Third Rock employs a four-stage approach to company creation: Discover, Launch, Build, Transform. In the Discovery phase, Third Rock works with scientific founders and expert advisors to develop a vision and strategy for a company. Once the company concept has been refined and optimized in Discovery, the firm launches the company with the necessary resources to enable it to reach critical milestones. Partners and other employees at the firm assume active roles on the company’s leadership team in the interim to ensure the execution of the company’s R&D strategy, and to build a world-class executive team. In the Build phase, Third Rock transitions out of interim roles and establish experienced and motivated management teams. Third Rock has invested in 53 companies; these companies are now bringing products to patients – Transforming their lives and the lives of their families. The firm’s portfolio of companies has launched 10 products, including five therapeutics, three diagnostics and two devices.[8]

References

  1. "Company Overview of Third Rock Ventures, LLC". Bloomberg L.P. Retrieved 22 June 2019.
  2. Third Rock Ventures Company Brochure
  3. Alsever, Jennifer (19 February 2015). "Third Rock Ventures: Giving birth to a new generation of biotechs". Fortune. Retrieved 22 August 2018.
  4. Weisman, Robert (31 October 2016). "Third Rock raises $616m for fourth biotech venture fund". Boston Globe. Retrieved 22 August 2018.
  5. Weintraub, Karen (5 June 2018). "Biotech Startups: Dreams, Risk, Failure And - Sometimes - Success". WBUR-FM. Retrieved 22 August 2018.
  6. Timmeran, Luke (31 October 2016). "Third Rock Ventures, One of Biotech's Daring Investors, Raises $616M For More Startups". Forbes. Retrieved 22 August 2018.
  7. Heidi Ledford (25 September 2013). "Biotechnology: The start-up engine". Nature. Retrieved 26 September 2013.
  8. "Approach". Thirdrockventures. Retrieved 2019-11-18.

Notes

  1. According to the December 2010 edition of BoogarLists' "Venture Capital + Private Equity Directory", the inception year for the company was 2007, not 2006. — Venture Captal + Private Equity. BoogerLists. December 30, 2010. p. 318 via Google Books.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.